What is Cannabis Bioscience International Holdings Inc.?
engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally.
CBIH · Verdict
Moderate reward · high risk
CBIH has limited near-term tailwinds — balance sheet and cash flow weigh on the model output.
Based on 88% data coverage
CBIH · Verdict
Current ratio 0.03
-109% free-cash-flow margin
Weak vs peers
-181% net margin · 0% ROE
Model-based scoring. For information only — not financial advice.
engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally. The company offers educational services, such as continuing medical education courses for physicians; continuing legal education courses for attorneys; certification courses for physicians; certification for industry workers; general education seminars; and on-site training, as well as consulting, digital publishing, marketing, and franchising related to medical cannabis through its Pharmacology University. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 4.65M.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.